N

Normunity

14 employees

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2021

Funding rounds raised

Total raised

$65M

from 3 investors over 3 rounds

N

Normunity raised $65M on October 25, 2022

Investors: Sanofi Ventures, Osage University Partners (OUP) and Canaan

FAQ